Charles Schwab Investment Management Inc Edgewise Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 497,162 shares of EWTX stock, worth $8.95 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
497,162
Previous 331,059
50.17%
Holding current value
$8.95 Million
Previous $3.62 Million
150.43%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding EWTX
# of Institutions
129Shares Held
76.3MCall Options Held
14.7KPut Options Held
14.8K-
Orbimed Advisors LLC San Diego, CA15MShares$271 Million6.17% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$105 Million1.35% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$93.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$72.4 Million0.0% of portfolio
-
Viking Global Investors LP3.34MShares$60.1 Million0.23% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.14B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...